Cargando…

Expression of LOX Suggests Poor Prognosis in Gastric Cancer

Background: Lysyl oxidase (LOX) is a key enzyme for the cross-linking of collagen and elastin in the extracellular matrix. This study evaluated the prognostic role of LOX in gastric cancer (GC) by analyzing the data of The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) dataset. Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jinfeng, Luo, Chen, Zhao, Jiefeng, Zhu, Xiaojian, Lin, Kang, Bu, Fanqin, Yu, Zhonglin, Zou, Feilong, Zhu, Zhengming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476844/ https://www.ncbi.nlm.nih.gov/pubmed/34595188 http://dx.doi.org/10.3389/fmed.2021.718986

Ejemplares similares

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
por: Huang, Chao, et al.
Publicado: (2020)

Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer
por: Lin, Kang, et al.
Publicado: (2020)

Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients
por: Bu, Fanqin, et al.
Publicado: (2020)

Long non-coding RNA RP11-59H7.3 promotes cell proliferation and invasion metastasis in colorectal cancer by miR-139-5p/NOTCH1 axis
por: Zhu, Xiaojian, et al.
Publicado: (2020)

RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling
por: Luo, Chen, et al.
Publicado: (2020)

A signature of 18 immune‐related gene pairs to predict the prognosis of pancreatic cancer patients
por: Bu, Fanqin, et al.
Publicado: (2020)

Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer
por: Zhu, Xiaojian, et al.
Publicado: (2020)

FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression
por: Zhu, Jinfeng, et al.
Publicado: (2022)

The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis
por: Peng, Xingyu, et al.
Publicado: (2023)

Comprehensive analysis of Syk gene methylation in colorectal cancer
por: Bu, Fanqin, et al.
Publicado: (2021)

Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer
por: Lin, Kang, et al.
Publicado: (2020)

Bioinformatics Analysis Identifies a Novel Role of GINS1 Gene in Colorectal Cancer
por: Bu, Fanqin, et al.
Publicado: (2020)

Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer
por: Liu, Sicheng, et al.
Publicado: (2022)

Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis
por: Zhao, Jiefeng, et al.
Publicado: (2022)

LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway
por: Luo, Chen, et al.
Publicado: (2021)

Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis
por: Zhao, Jiefeng, et al.
Publicado: (2021)

High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells
por: Zhang, Yu, et al.
Publicado: (2023)

Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer
por: Zeng, Jianmin, et al.
Publicado: (2021)

Prognostic Nomogram of Prognosis-Related Genes and Clinicopathological Characteristics to Predict the 5-Year Survival Rate of Colon Cancer Patients
por: Huang, Chao, et al.
Publicado: (2021)

Down-regulated expression of CDK5RAP3 and UFM1 suggests a poor prognosis in gastric cancer patients
por: Lin, Mi, et al.
Publicado: (2022)

Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer
por: Wu, Jiacheng, et al.
Publicado: (2021)

High expression of GMⅡ is associated with poor prognosis of gastric cancer patients
por: Zhu, Shasha, et al.
Publicado: (2019)

lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer
por: Nai, Aitao, et al.
Publicado: (2022)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Flotillin2 Expression Correlates with HER2 Levels and Poor Prognosis in Gastric Cancer
por: Zhu, Zhi, et al.
Publicado: (2013)

Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015)

Higher expression of pseudouridine synthase 7 promotes non-small cell lung cancer progression and suggests a poor prognosis
por: Zhang, Guihong, et al.
Publicado: (2023)

Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer
por: He, Fang, et al.
Publicado: (2022)

LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
por: Yang, Wei, et al.
Publicado: (2021)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1
por: Mentrup, Torben, et al.
Publicado: (2021)

UBR5 oncogene as an indicator of poor prognosis in gastric cancer
por: Ding, Fanghui, et al.
Publicado: (2020)

Prevalence of and prognosis for poor immunological recovery by virally suppressed and aged HIV-infected patients
por: Fan, Lina, et al.
Publicado: (2023)

Upregulated expression of LOX is a novel independent prognostic marker of worse outcome in gastric cancer patients after curative surgery
por: ZHANG, QING, et al.
Publicado: (2013)

Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
por: Yang, Wei, et al.
Publicado: (2022)

High expression of GNB4 predicts poor prognosis in patients with Helicobacter pylori-positive advanced gastric cancer
por: Gao, Jianpeng, et al.
Publicado: (2020)

Establishment of Decision Rules and Risk Assessment Model for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer
por: Huang, Chao, et al.
Publicado: (2020)

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke
por: Zheng, Yangmin, et al.
Publicado: (2021)

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer
por: Váncza, Lóránd, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lkuqdnhq321na6clkufcsem290